Skip to content

Study · Not a test of the peptide alone · 2005

1 result

Detection and removal of lead using lead-binding proteins

LOWE ADRIAN M, COLPAS GERARD J, HAMILTON MAUREEN A, SALCIUS MICHAEL J, SANDERS MITCHELL C

Journal not recorded22 Sept 2004

PepBankPUB-99168289
Source linkAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Activity measurement

    Thymosin beta‑4, thymosin beta-9 and acyl-CoA binding protein were reported to bind lead, with a high-affinity lead-binding region.

    In plain wordsIn lab terms, thymosin beta‑4, thymosin beta-9 and one other protein were reported to bind lead strongly.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableLead binding affinity
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Thymosin beta-4 (TB4), Thymosin beta-9 (TB9), and acyl-CoA binding protein (ACBP) are two proteins that possess the ability to bind lead in human tissue. These two proteins have a high affinity lead-binding region with a dissociation constant (Kd) of about 10<-9 >M that allows for a strong interacti…

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.